Global Prenatal Diagnostics Market to Reach $14.2 Billion by 2030
The global market for Prenatal Diagnostics estimated at US$4.7 Billion in the year 2022, is projected to reach a revised size of US$14.2 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030. Non-Invasive, one of the segments analyzed in the report, is projected to record 18.3% CAGR and reach US$10.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Invasive segment is readjusted to a revised 7.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 20.8% CAGR
The Prenatal Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 20.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 12.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.Select Competitors (Total 43 Featured) -
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America® Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America® Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | April 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 4 Billion |
Forecasted Market Value ( USD | $ 9.3 Billion |
Compound Annual Growth Rate | 12.8% |
Regions Covered | Global |